Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 5Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, T-Cell 2Burkitt Lymphoma 2Sezary Syndrome 1Sarcoma, Ewing 1Retinoblastoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Mycosis Fungoides 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Vincristine 1Radiotherapy 1Maintenance Chemotherapy 1Lomustine 1Induction Chemotherapy 1Diploidy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Neuroectodermal Tumors, Primitive × Vincristine × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡